Tones MA

References (3)

Title : Elevating brain GLP-1 and GIP levels as a treatment strategy for neurodegenerative disorders - Greig_2025_Alzheimers.Dement_20_e089262
Author(s) : Greig NH , Wang Y , Hoffer BJ , Sambamurti K , Lahiri DK , Tones MA , Zaleska MM , Mattison JA
Ref : Alzheimers Dement , 20 :e089262 , 2025
Abstract :
PubMedSearch : Greig_2025_Alzheimers.Dement_20_e089262
PubMedID:

Title : DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease - Yu_2024_Geroscience__
Author(s) : Yu SJ , Wang Y , Shen H , Bae EK , Li Y , Sambamurti K , Tones MA , Zaleska MM , Hoffer BJ , Greig NH
Ref : Geroscience , : , 2024
Abstract :
PubMedSearch : Yu_2024_Geroscience__
PubMedID: 38563864

Title : Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders - Li_2024_Geroscience__
Author(s) : Li Y , Vaughan KL , Wang Y , Yu SJ , Bae EK , Tamargo IA , Kopp KO , Tweedie D , Chiang CC , Schmidt KT , Lahiri DK , Tones MA , Zaleska MM , Hoffer BJ , Mattison JA , Greig NH
Ref : Geroscience , : , 2024
Abstract :
PubMedSearch : Li_2024_Geroscience__
PubMedID: 38532069